Nicholas Short

200PUBLICATIONS

261CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRegenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (200)

Sort by Publication Date:

|Jun 27, 2026

Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.

|Jun 22, 2026

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|May 27, 2026

Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|May 06, 2026

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Apr 09, 2026

Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia.

Hagop Kantarjian, Wei Qiao, Nitin Jain

|Mar 28, 2026

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Alexandre Bazinet, Alex Bataller, Kelly Chien

Pageof 34

Frequent Collaborators

124 joint publications

Elias Jabbour

116 joint publications

Hagop M Kantarjian

113 joint publications

Tapan M Kadia

109 joint publications

Navel G Daver

103 joint publications

Courtney DiNardo

88 joint publications

Koji Sasaki

84 joint publications

Farhad Ravandi

79 joint publications

Guillermo Garcia-Manero

69 joint publications

Gautam Borthakur

58 joint publications

Ghayas Issa